Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells

被引:1252
作者
Seddiki, Nabila
Santner-Nanan, Brigitte
Martinson, Jeff
Zaunders, John
Sasson, Sarah
Landay, Alan
Solomon, Michael
Selby, Warwick
Alexander, Stephen I.
Nanan, Ralph
Kelleher, Anthony
Fazekas de St Groth, Barbara [1 ]
机构
[1] Univ Sydney, Fac Med, Centenary Inst Canc Med & Cell Biol, Newtown, NSW 2042, Australia
[2] St Vincents Hosp, Ctr Immunol, Darlinghurst, NSW 2010, Australia
[3] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW 2052, Australia
[4] Univ Sydney, Western Clin Sch, Dept Paediat, Penrith, NSW 2751, Australia
[5] Rush Univ, Med Ctr, Dept Immunol & Microbiol, Chicago, IL 60612 USA
[6] Royal Prince Alfred Hosp, Dept Gastroenterol, Camperdown, NSW 2050, Australia
[7] Childrens Hosp, Westmead, NSW 2145, Australia
关键词
D O I
10.1084/jem.20060468
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Abnormalities in CD4(+) CD25(+) Foxp3(+) regulatory T (T reg) cells have been implicated in susceptibility to allergic, autoimmune, and immunoinflammatory conditions. However, phenotypic and functional assessment of human T reg cells has been hampered by difficulty in distinguishing between CD25-expressing activated and regulatory T cells. Here, we show that expression of CD127, the alpha chain of the interleukin-7 receptor, allows an unambiguous flow cytometry-based distinction to be made between CD127(lo) T reg cells and CD127(hi) conventional T cells within the CD25(+) CD45RO(+) RA(-) effector/memory and CD45RA(+) RO- naive compartments in peripheral blood and lymph node. In healthy volunteers, peripheral blood CD25(+) CD127(lo) cells comprised 6.35 +/- 0.26% of CD4(+) T cells, of which 2.05 +/- 0.14% expressed the naive subset marker CD45RA. Expression of FoxP3 protein and the CD127lo phenotype were highly correlated within the CD4(+) CD25(+) population. Moreover, both effector/memory and naive CD25(+) CD127(lo) cells manifested suppressive activity in vitro, whereas CD25(+) CD127(hi) cells did not. Cell surface expression of CD127 therefore allows accurate estimation of T reg cell numbers and isolation of pure populations for in vitro studies and should contribute to our understanding of regulatory abnormalities in immunopathic diseases.
引用
收藏
页码:1693 / 1700
页数:8
相关论文
共 29 条
[1]   The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs [J].
Allan, SE ;
Passerini, L ;
Bacchetta, R ;
Crellin, N ;
Dai, MY ;
Orban, PC ;
Ziegler, SF ;
Roncarolo, MG ;
Levings, MK .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (11) :3276-3284
[2]   CD4+CD25high regulatory cells in human peripheral blood [J].
Baecher-Allan, C ;
Brown, JA ;
Freeman, GJ ;
Hafler, DA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1245-1253
[3]   MHC class II expression identifies functionally distinct human regulatory T cells [J].
Baecher-Allan, Clare ;
Wolf, Elizabeth ;
Haller, David A. .
JOURNAL OF IMMUNOLOGY, 2006, 176 (08) :4622-4631
[4]   CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease [J].
Cao, DJ ;
van Vollenhoven, R ;
Klareskog, L ;
Trollmo, C ;
Malmström, V .
ARTHRITIS RESEARCH & THERAPY, 2004, 6 (04) :R335-R346
[5]   Cutting edge:: Self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T cells [J].
Cozzo, C ;
Larkin, J ;
Caton, AJ .
JOURNAL OF IMMUNOLOGY, 2003, 171 (11) :5678-5682
[6]   Quantification of regulatory T cells in patients with systemic lupus erythematosus [J].
Crispin, JC ;
Martínez, A ;
Alcocer-Varela, J .
JOURNAL OF AUTOIMMUNITY, 2003, 21 (03) :273-276
[7]   Development and activation of regulatory T cells in the human fetus [J].
Cupedo, T ;
Nagasawa, M ;
Weijer, K ;
Blom, B ;
Spits, H .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2005, 35 (02) :383-390
[8]   Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy [J].
Ehrenstein, MR ;
Evans, JG ;
Singh, A ;
Moore, S ;
Warnes, G ;
Isenberg, DA ;
Mauri, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (03) :277-285
[9]   CD25+ CD4+ regulatory T cells in patients with Kawasaki disease [J].
Furuno, K ;
Yuge, T ;
Kusuhara, K ;
Takada, H ;
Nishio, H ;
Khajoee, V ;
Ohno, T ;
Hara, T .
JOURNAL OF PEDIATRICS, 2004, 145 (03) :385-390
[10]   Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo [J].
Gavin, MA ;
Clarke, SR ;
Negrou, E ;
Gallegos, A ;
Rudensky, A .
NATURE IMMUNOLOGY, 2002, 3 (01) :33-41